In Brief This Week: Thermo Fisher Scientific; PGXL Labs; Phenomenex; CBLPath; University of Tennessee; Response Genetics; StemCells | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said this week it has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR for $480 million in cash. Cole-Parmer, part of Thermo Fisher's Laboratory Products and Services segment, provides fluid handling, test and measurement, and electrochemistry products and services. It has 400 employees worldwide and recorded $230 million in revenues last year. The deal is expected to close in the third quarter and is anticipated to have no material impact on Thermo Fisher's adjusted EPS.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.